Botanix Pharmaceuticals Limited (ASX:BOT)

Botanix Pharmaceuticals Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	64.97	79.31	10.25	7.29	21.55
Cash & Short-Term Investments	64.97	79.31	10.25	7.29	21.55
Cash Growth	-18.08%	673.71%	40.69%	-66.20%	-12.54%
Accounts Receivable	2.85	0.46	0.4	-	-
Other Receivables	0.35	0.36	0.09	0.14	0.05
Receivables	3.2	0.82	0.49	0.14	0.05
Inventory	28.08	1.21	3.15	3.04	-
Prepaid Expenses	3.34	0.1	0.09	0.03	0.01
Other Current Assets	-	1.47	-	-	-
Total Current Assets	99.59	82.9	13.98	10.5	21.61
Property, Plant & Equipment	1.38	0.07	0.07	0.18	0.28
Other Intangible Assets	28.12	29.49	6.86	3.3	-
Long-Term Deferred Charges	-	-	3.87	-	-
Other Long-Term Assets	-	-	0.06	0.06	0.06
Total Assets	129.1	112.46	24.84	14.04	21.95
Accounts Payable	8.87	2.73	1.39	4.68	0.65
Accrued Expenses	3.94	0.56	0.15	0.1	0.09
Current Portion of Leases	0.41	-	-	0.12	0.15
Other Current Liabilities	11.7	0.44	0.34	0.99	0.15
Total Current Liabilities	24.92	3.73	1.88	5.89	1.04
Long-Term Leases	0.81	-	-	-	0.11
Other Long-Term Liabilities	22.07	-	-	-	-
Total Liabilities	47.8	3.73	1.88	5.89	1.15
Common Stock	226.3	188.32	93.49	71.48	71.48
Retained Earnings	-177.19	-90.79	-76.92	-67.77	-54.6
Comprehensive Income & Other	32.18	11.2	6.38	4.44	3.92
Shareholders' Equity	81.3	108.73	22.95	8.15	20.8
Total Liabilities & Equity	129.1	112.46	24.84	14.04	21.95
Total Debt	1.22	-	-	0.12	0.26
Net Cash (Debt)	63.75	79.31	10.25	7.16	21.3
Net Cash Growth	-19.62%	673.71%	43.10%	-66.36%	-12.09%
Net Cash Per Share	0.03	0.05	0.01	0.01	0.02
Filing Date Shares Outstanding	1,961	1,814	1,421	1,085	973.14
Total Common Shares Outstanding	1,961	1,810	1,312	973.14	973.14
Working Capital	74.67	79.17	12.09	4.62	20.57
Book Value Per Share	0.04	0.06	0.02	0.01	0.02
Tangible Book Value	53.17	79.24	16.1	4.86	20.8
Tangible Book Value Per Share	0.03	0.04	0.01	0.00	0.02

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.